Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 591, pseudogene (RN7SL591P) is classified as a pseudogene derived from the 7SL RNA gene family[1][8]. The 7SL RNA is the RNA component of the signal recognition particle (SRP), a highly conserved ribonucleoprotein complex essential for targeting newly synthesized secretory proteins to the endoplasmic reticulum in eukaryotes; however, RN7SL591P itself is a non-functional pseudogene, meaning it does not encode a functional RNA or protein product[1][4][8]. In the human genome, there are hundreds of loci similar to 7SL RNA, but the vast majority are pseudogenes likely generated by the reverse transcription and reinsertion of 7SL RNA sequences, often existing as truncated or fragmented sequences incapable of normal biological activity[5][9]. There is no evidence that RN7SL591P serves as a therapeutic target or has functional roles in disease or normal cellular processes, and it is not associated with known biomarkers, drug interactions, or safety concerns[1][8]. Its classification is strictly as a non-coding processed pseudogene[4][8]. Key context and explanation: - RN7SL591P is officially recognized by the HUGO Gene Nomenclature Committee as a processed pseudogene[8]. - Pseudogenes such as RN7SL591P arise via reverse transcription of mRNA, generating non-functional DNA inserts; they generally have no coding, regulatory, or receptor activity[4][5]. - While the functional 7SL RNA plays a major cellular role as part of the SRP in protein targeting to the endoplasmic reticulum[3][7], the pseudogene copies (including RN7SL591P) do not participate in this pathway and have no established biological or disease function. - There are no drugs or mechanisms of action targeting this pseudogene, distinguishing it from functional molecular targets. If you require more information about the functional 7SL RNA (not the pseudogene), or another member of the SRP family, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 591, pseudogene (RN7SL591P).